Results 31 to 40 of about 29,428 (269)

Left ventricular assist device implantation as bridge to heart transplantation [PDF]

Scripta Medica, 2017
Heart transplantation is a method of choice for the surgical treatment of a terminal stage of cardiac insufficiency. The lack of donors that all health systems in the world are experiencing has led to the intensive development of devices for permanent ...
Terzić Duško, Putnik Svetozar, Nestorović Emilija, Marković Dejan, Ristić Miljko   +4 more
doaj  

Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundThere are few data describing the longitudinal use of and adherence to heart failure medications following left ventricular assist device (LVAD) implantation.
Nicholas Y. Tan, Lindsey R. Sangaralingham, Stephanie R. Schilz, Shannon M. Dunlay   +3 more
doaj   +1 more source

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States

Medicina, 2020
Background: Left ventricular assist device (LVAD) therapy has improved the clinical outcomes in advanced heart failure patients, however, this may differ between countries. We aimed to compare outcomes between Japanese and US LVAD cohorts.
Teruhiko Imamura, Minoru Ono, Koichiro Kinugawa, Norihide Fukushima, Akira Shiose, Yoshiro Matsui, Kenji Yamazaki, Yoshikatsu Saiki, Akihiko Usui, Hiroshi Niinami, Goro Matsumiya, Hirokuni Arai, Yoshiki Sawa, Nir Uriel   +13 more
doaj   +1 more source

Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]

, 2020
BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric, Elkind, Jae, Morris, Gerald P, Ostberg-Braun, Oscar, Silva Enciso, Jorge, Sobczyk, Juliana   +5 more
core   +1 more source

Significance of right ventricular function for the outcome of treatment and remodeling of the heart after left ventricular assist device implantation [PDF]

Medicinski Podmladak, 2022
The efficiency of the device for permanent circulatory support of the left ventricle has been proven through clinical practice with the trend of constant improvement of treatment results along with biotechnological progress and improvement of surgical ...
Terzić Duško, Mikić Aleksandar
doaj  

The impact of peripheral arterial disease on patients with mechanical circulatory support. [PDF]

, 2020
Background: Left ventricular assist devices (LVAD) are indicated as bridging or destination therapy for patients with advanced (Stage D) heart failure and reduced ejection fraction (HFrEF). Due to the clustering of the mutual risk factors, HFrEF patients
Ajmal, Rasikh, Al-Khadra, Yasser, Alraies, M Chadi, Asfour, Abedelrahim, Darmoch, Fahed, Gardi, Delair, Glazier, James, Mir, Tanveer, Moussa-Pacha, Homam, Sattar, Yasar, Ullah, Waqas   +10 more
core   +1 more source

Heart Failure Anticoagulation Teach-Back Education and Readmissions [PDF]

, 2020
: Heart failure affects millions of Americans each year. Treatment of advanced heart failure with reduced ejection fraction and left ventricular failure is sometimes treated with implantation of a left-ventricular assist device.

core  

Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support

Scientific Reports, 2021
The association between ventricular arrhythmias (VAs) and mortality in patients supported by continuous flow left ventricular assist devices (LVAD) remains controversial.
Zeina Jedeon, Rebecca Cogswell, Jessica Schultz, Lisa Von Wald, Ranjit John, Henri Roukoz   +5 more
doaj   +1 more source

A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide

Frontiers in Cardiovascular Medicine, 2022
The use of a left ventricular assist device (LVAD) as a bridge-to-transplantation or destination therapy to support cardiac function in patients with end-stage heart failure (HF) is increasing in all developed countries.
Matteo Cameli, Maria Concetta Pastore, Giulia Elena Mandoli, Federico Landra, Matteo Lisi, Matteo Lisi, Luna Cavigli, Flavio D'Ascenzi, Marta Focardi, Chiara Carrucola, Aleksander Dokollari, Gianluigi Bisleri, Charilaos Tsioulpas, Sonia Bernazzali, Massimo Maccherini, Serafina Valente   +15 more
doaj   +1 more source

Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set. [PDF]

, 2017
BACKGROUND: Studies on stroke risk following cardiac procedures addressed only perioperative and long-term risk following limited higher-risk procedures, were poorly generalizable, and often failed to stratify by stroke type. We calculated stroke risk in
Dhamoon, Amit S., Dhamoon, Mandip S., Liang, John W., Stein, Laura, Thaler, Alison, Tuhrim, Stanley   +5 more
core   +2 more sources